Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Ratios

Alto Neuroscience (ANRO) Preferred Shares Issued (2023)

Alto Neuroscience has reported Preferred Shares Issued over the past 1 years, most recently at $45.0 million for Q4 2023.

Quarterly results put Preferred Shares Issued at $45.0 million for Q4 2023, changed N/A from a year ago — trailing twelve months through Sep 2024 was $45.0 million (changed N/A YoY), and the annual figure for FY2023 was $70.0 million, changed.
Preferred Shares Issued reached $45.0 million in Q4 2023 per ANRO's latest filing, up from $25.0 million in the prior quarter.
Across five years, Preferred Shares Issued topped out at $45.0 million in Q4 2023 and bottomed at $25.0 million in Q1 2023.